The FDA Has Updated Regeneron Pharmaceuticals/Sanofi's Dupixent (Dupilumab) Label In Atopic Dermatitis, Adding Efficacy, Safety Data For Patients Aged 12 Years And Older With Atopic Dermatitis With Moderate To Severe Hand And Foot Involvement
Benzinga Newsdesk - Jan 16, 2024, 7:06AM